Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
114 EUR | +0.13% | -.--% | -.--% |
May. 07 | Dsm-Firmenich Ag Approves Retirement of Pradeep Pant from the Board | CI |
May. 07 | Dsm-Firmenich Ag Approves the Dividend, Payable May 16, 2024 | CI |
Sales 2024 * | 12.63B 13.71B | Sales 2025 * | 13.3B 14.44B | Capitalization | 28.69B 31.14B |
---|---|---|---|---|---|
Net income 2024 * | 452M 491M | Net income 2025 * | 781M 848M | EV / Sales 2024 * | 2.5 x |
Net Debt 2024 * | 2.87B 3.11B | Net Debt 2025 * | 2.61B 2.84B | EV / Sales 2025 * | 2.35 x |
P/E ratio 2024 * |
63.4
x | P/E ratio 2025 * |
36.6
x | Employees | 28,685 |
Yield 2024 * |
2.33% | Yield 2025 * |
2.29% | Free-Float | 25.03% |
Latest transcript on Koninklijke DSM
1 day | +0.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 89-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 23-01-31 | |
Thomas Leysen
CHM | Chairman | 63 | 23-01-31 |
Director/Board Member | 62 | 23-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.43% | 304 M€ | +16.83% | ||
1.13% | 17 M€ | +7.97% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.34% | 892B | |
+0.10% | 239B | |
+26.22% | 174B | |
-2.95% | 133B | |
+46.85% | 86.48B | |
-4.80% | 74.78B | |
-5.56% | 58.22B | |
+40.97% | 37.79B | |
-30.32% | 37.46B |
- Stock Market
- Equities
- DSFIR Stock
- DSM Stock